PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New model enables the study of how protein complex influences mitochondrial function

A yeast experiment conducted at a FAPESP-supported research center shows how deficiencies in the proteasome, which is responsible for eliminating damaged and non-functional proteins, affect the metabolism of mitochondria

2025-06-27
(Press-News.org) A study by the Center for Redox Processes in Biomedicine (Redoxoma) led by Marilene Demasi from the Butantan Institute (São Paulo, Brazil) presents a valuable new experimental model for investigating the interaction between the proteasome and mitochondrial function. In eukaryotic cells, the proteasome is a protein complex responsible for eliminating damaged and nonfunctional proteins, thereby helping to maintain cellular balance and proper functioning.

In recent years, studies have revealed that the proteasome and mitochondria are more closely connected than previously thought. The proteasome plays a role in the quality control of proteins destined for the mitochondria, while mitochondrial metabolism affects the efficiency with which proteins marked for destruction are degraded.

Redoxoma, a Research, Innovation and Dissemination Center (RIDC) of FAPESP based at the University of São Paulo’s Institute of Chemistry (IQ-USP) conducted research focusing on the effects of proteasome dysfunction in the C76S mutant strain of the yeast Saccharomyces cerevisiae. The study revealed that deficiency in this system leads to increased mitochondrial oxidative stress. This was evidenced by increased hydrogen peroxide (H2O2) release and a lower peroxiredoxin 1 (Prx1) concentration. Prx1 is a crucial enzyme in the removal of peroxides. In mammals, mitochondrial Prx3 is equivalent to Prx1 in yeast.

“The most important thing about this work is that we’ve a yeast strain that can serve as a model for investigating proteasome deficiency in relation to mitochondrial metabolism, a model that didn’t yet exist in the literature,” Demasi points out.

The study was published in an article in the journal Archives of Biochemistry and Biophysics.

Next steps

The researchers are now working to understand why Prx1 levels decrease in cells with compromised proteasomes. “We don’t yet know if there was a decrease in Prx1 gene expression, which is possible, since the proteasome also plays a role in gene transcription regulation, or if the protein oxidizes more. It may hyperoxidize and, as a result, be degraded more. Perhaps the excess peroxide is promoting its continuous degradation,” says the researcher at the Butantan Institute.

To answer these questions, the group plans to conduct comparative transcriptome and proteomic analyses of the wild and mutant strains cultivated under respiratory conditions. The goal is to establish this strain as a model for studying the role of the ubiquitin-proteasome system in cell metabolism.

About São Paulo Research Foundation (FAPESP)
The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.

END


ELSE PRESS RELEASES FROM THIS DATE:

Device study offers hopes for spinal cord injuries

2025-06-27
Spinal cord injuries are currently incurable with devastating effects on people’s lives, but now a trial at Waipapa Taumata Rau, University of Auckland offers hope for an effective treatment. Spinal cord injuries shatter the signal between the brain and body, often resulting in a loss of function.“Unlike a cut on the skin, which typically heals on its own, the spinal cord does not regenerate effectively, making these injuries devastating and currently incurable,” says lead researcher Dr Bruce Harland, a senior research fellow in the School of Pharmacy at Waipapa Taumata Rau, University of Auckland. Before birth, and to a lesser extent afterwards, ...

How urea forms spontaneously

2025-06-27
Urea is one of the most important industrial chemicals produced worldwide. It is used as a fertiliser, for the production of synthetic resins and explosives and as a fuel additive for cleaning car exhaust gases. Urea is also believed to be a potential key building block for the formation of biological molecules such as RNA and DNA in connection with the question of the origin of life (see ETH News from 28 June 2023). Until now, the origin of urea itself on Early Earth has not been conclusively clarified. A research team led by Ruth Signorell, Professor of Physical Chemistry ...

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan

2025-06-27
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan — a transformative advance in early, accurate diagnosis.  The tool, StateViewer, helped researchers identify the dementia type in 88% of cases, according to research published online on June 27, 2025, in Neurology, the medical journal of the American Academy of Neurology. It also enabled clinicians to interpret brain scans ...

Gene therapy improves blood flow in the brain in patients with sickle cell disease

2025-06-27
(MEMPHIS, Tenn. – June 27, 2025) Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children’s Research Hospital. Many people with sickle cell disease experience increased brain ischemia, where oxygen is not delivered properly to brain tissues, potentially leading to strokes. A part of the risk for these events comes from increased blood flow speed in the brain. Findings from three patients in a gene therapy clinical trial showed ...

Building breast tissue in the lab to better understand lactation

2025-06-27
Human breast milk is uniquely adapted to meet an infant’s nutritional needs. Surprisingly, we still know very little about how milk is even made in the breast. A team of ETH Zurich researchers led by Marcy Zenobi-Wong, Professor of Tissue Engineering and Biofabrication, want to change that. In the lab, Zenobi-Wong and her team developed tiny replicas of lactating breast tissue. This involved isolating cells from human breast milk that are naturally found in milk. Some of the cells from lactating breast tissue and the so-called lactocytes – the cells in breast tissue that produce milk – end up in ...

How gut bacteria change after exposure to pesticides

2025-06-27
COLUMBUS, Ohio – While emerging evidence suggests pesticides can be toxic to the mix of microorganisms in the digestive system, a new study is the first to map changes to specific gut bacteria based on interactions between human microbes and insect-killing chemicals observed in the lab and an animal model. The analysis showed that over a dozen pesticides influence human gut bacteria growth patterns, affect how gut microorganisms process nutrients and camp out inside some bacteria. Researchers say the resulting “atlas” ...

Timepoint at which developing B-cells become cancerous impacts leukemia treatment

2025-06-27
New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL). Scientists at St. Jude Children’s Research Hospital and University Health Network’s Princess Margaret Cancer Centre, Toronto, developed a robust single-cell reference atlas of normal human B-cell development and cross-referenced single-cell B-ALL data with it, as well as outcomes data. The study, ...

Roberto Morandotti wins prestigious IEEE Photonics Society Quantum Electronics Award 

2025-06-27
Roberto Morandotti Wins Prestigious IEEE Photonics Society Quantum Electronics Award    Congratulations to Professor Roberto Morandotti, the first researcher at INRS to receive this prestigious award in the field of quantum electronics    VARENNES, QC, June 27, 2025 – Professor Roberto Morandotti, a globally recognized leader in quantum optics and photonics at the Institut national de la recherche scientifique (INRS), has won the 2025 Institute of Electrical and Electronics Engineers (IEEE) Photonic Society Quantum Electronics Award. This award pays ...

New urine-based tumor DNA test may help personalize bladder cancer treatment

2025-06-27
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment. This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine urine samples from 89 patients at the start of treatment and from 77 patients three months later. The goal was to see if utDNA could help identify which bladder cancer patients are most likely to respond to immunotherapy.  “This approach could help improve patient ...

How a faulty transport protein in the brain can trigger severe epilepsy

2025-06-27
Citrate is essential for the metabolism and development of neurons. A membrane transport protein called SLC13A5 plays a central role in this process and has previously been linked to a particularly severe form of epileptic encephalopathy. Building on data from the recently completed RESOLUTE and REsolution flagship projects, scientists at CeMM have comprehensively studied the function and structure of the membrane transporter SLC13A5, experimentally investigating 38 mutant variants. Their findings, published in Science Advances (DOI 10.1126/sciadv.adx3011) shed new light on the mechanisms of this disease and lay the ...

LAST 30 PRESS RELEASES:

Malnutrition in children rises when economy drops

New model enables the study of how protein complex influences mitochondrial function

Device study offers hopes for spinal cord injuries

How urea forms spontaneously

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan

Gene therapy improves blood flow in the brain in patients with sickle cell disease

Building breast tissue in the lab to better understand lactation

How gut bacteria change after exposure to pesticides

Timepoint at which developing B-cells become cancerous impacts leukemia treatment

Roberto Morandotti wins prestigious IEEE Photonics Society Quantum Electronics Award 

New urine-based tumor DNA test may help personalize bladder cancer treatment

How a faulty transport protein in the brain can trigger severe epilepsy

Study reveals uneven land sinking across New Orleans, raising flood-risk concerns

Researchers uncover novel mechanism for regulating ribosome biogenesis during brain development

RNA codon expansion via programmable pseudouridine editing and decoding

Post-diagnosis emergency department presentation and demographic factors in malignant skin cancers

A new genetic tuner for embryo development

Insurance churn and the COVID-19 pandemic

Postpartum Medicaid use in birthing parents and access to financed care

Manufacturing chemicals via orthogonal strategy, making full use of waste plastic resources in real life

Study overturns long-held belief about shape of fish schools

Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from esophageal adenocarcinoma

Verify the therapeutic effect of effective components of lycium barbarum on hepatocellular carcinoma based on molecular docking

Early intervention changes trajectory for depressed preschoolers

HonorHealth Research Institute presents ‘monumental’ increase in survivability for patients suffering ultra-low blood pressure

Mitochondrial dynamics in breast cancer metastasis: From metabolic drivers to therapeutic targets

Removing out-of-pocket fee improves access to 3D mammography

Does reducing exposure to image and video content on messaging apps reduce the impact of misinformation? Yes and no

A global microbiome preservation effort enters its growth phase

New credit card-sized TB test could close the diagnostic gap in HIV hotspots

[Press-News.org] New model enables the study of how protein complex influences mitochondrial function
A yeast experiment conducted at a FAPESP-supported research center shows how deficiencies in the proteasome, which is responsible for eliminating damaged and non-functional proteins, affect the metabolism of mitochondria